XML 16 R4.htm IDEA: XBRL DOCUMENT v3.22.2
UNAUDITED CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY
$ in Thousands
USD ($)
shares
Common shares
USD ($)
shares
Contributed surplus
USD ($)
Accumulated other comprehensive income
USD ($)
Deficit
USD ($)
Balance at beginning of period (in shares) at Dec. 31, 2020 | shares   32,630,536      
Balance at beginning of period at Dec. 31, 2020 $ 200,306 $ 264,357 $ 2,537 $ 1,699 $ (68,287)
Exercise of stock options (in shares) | shares 86,684 86,684      
Exercise of stock options $ 184 $ 264 (80)    
Share-based compensation 917   917    
Comprehensive loss (7,568)     5,266 (12,834)
Balance at end of period (in shares) at Jun. 30, 2021 | shares   32,717,220      
Balance at end of period at Jun. 30, 2021 193,839 $ 264,621 3,374 6,965 (81,121)
Balance at beginning of period (in shares) at Dec. 31, 2021 | shares   32,857,422      
Balance at beginning of period at Dec. 31, 2021 $ 190,656 $ 266,119 4,312 2,113 (81,888)
Exercise of stock options (in shares) | shares 6,409 6,409      
Exercise of stock options $ 53 $ 101 (48)    
Share-based compensation 2,624   2,624    
Shares issued in connection with acquisitions (in shares) | shares   15,364      
Shares issued related to contingent consideration 700 $ 700      
Share issuance under employee share purchase plan (in shares) | shares   6,377      
Share issuance under employee share purchase plan 304 $ 361 (57)    
Comprehensive loss (6,799)     (1,943) (4,856)
Balance at end of period (in shares) at Jun. 30, 2022 | shares   32,885,572      
Balance at end of period at Jun. 30, 2022 $ 187,538 $ 267,281 $ 6,831 $ 170 $ (86,744)